DiscoverFuture of Drug DiscoveryRahmad Akbar - Frontiers of AI Antibody Design (FODD #17)
Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Update: 2024-09-03
Share

Description

This episode is a discussion between ⁠Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse⁠.


You will learn:



  • The impact antibody design has on the world.

  • How AI is helping to push antibody design forward, bringing new therapies to patients.

  • What will antibody design look like in the future?




Rahmad's LinkedIn page.


Rahmad's Personal Website.


Antibody Origami: Here.


Rahmad's Previous and Existing Team: Victor Greiff (GreiffLab). Paolo Marcatili, Ludovica Beltrame, Rasmus Høiberg-Nielsen (Antibody Design at Novo Nordisk).




"And a big shout out to budding antibody designers (scientists) everywhere especially from my home country Indonesia!' - Rahmad.



Be sure to like, rate and review the podcast if you enjoyed this episode!

Visit our website: https://www.antiverse.io/

Follow us:
LinkedIn: ⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠⁠⁠
X: ⁠⁠⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Rahmad Akbar - Frontiers of AI Antibody Design (FODD #17)

Murat Tunaboylu